Adrianne E. Rogers, MD

Emeritus Professor, Pathology & Laboratory Medicine

Adrianne Rogers


Dr. Rogers earned a Doctor of Medicine in 1958 from Harvard University, from which she graduated with honors. This accomplishment was preceded by a Bachelor’s degree from Radcliffe College, and certifications from the American Board of Pathology as well as the American Board of Toxicology. Demonstrating unmatched versatility in her field, Dr. Rogers worked as an interim associate dean of academic affairs at Boston University from 2006 to 2007, having previously served the institution as director of the office of medical education, pathology professor and associate chair of pathology.

Dr. Rogers’ additional professional experience encompasses contributions as a senior research scientist and research associate at the Massachusetts Institute of Technology. She found further success as an associate pathologist at Boston City Hospital. Dr. Rogers also completed a research fellowship in the pathology department at Harvard University Medical School’s Mallory Institute.

An affluent lecturer in her field, Dr. Rogers has been active an instructor at Harvard University Medical School as well as the University Hospital of Boston. Her professional experience is extensive, and she has also served on several boards and panels including the board of science counselors for the research division of the National Toxicology Program and the expert panel for the Research Institute for Fragrance Materials. Notable for her contributions to the field of medical education and her influence on curriculum changes, Dr. Rogers is also an accomplished author in her industry, having penned myriad articles for numerous professional journals.

Due to her interest in community involvement, Dr. Rogers has been a member of the Mystic Watershed Association since 1975 and a trustee of the Forsyth Dental Center since 1987. She has maintained involvement as a co-chair of the Friends of the Upper Mystic Lake. Due to her prominence in her field, Dr. Rogers is affiliated with the American Association of Pathologists, the Federation of American Societies for Experimental Biology, the American Institute of Nutrition, the New England Society of Pathologists, the American Association for Cancer Research and the Society of Toxicology.


  • Harvard University, MD
  • Radcliffe College, AB


  • Published on 12/1/2008

    Kovacheva VP, Davison JM, Mellott TJ, Rogers AE, Yang S, O'Brien MJ, Blusztajn JK. Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival. FASEB J. 2009 Apr; 23(4):1054-63. PMID: 19047067.

    Read at: PubMed
  • Published on 12/15/2007

    Belguise K, Guo S, Yang S, Rogers AE, Seldin DC, Sherr DH, Sonenshein GE. Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype. Cancer Res. 2007 Dec 15; 67(24):11742-50. PMID: 18089804.

    Read at: PubMed
  • Published on 3/16/2007

    Panasyuk SV, Yang S, Faller DV, Ngo D, Lew RA, Freeman JE, Rogers AE. Medical hyperspectral imaging to facilitate residual tumor identification during surgery. Cancer Biol Ther. 2007 Mar; 6(3):439-46. PMID: 17374984.

    Read at: PubMed
  • Published on 8/1/2005

    Murray SA, Yang S, Demicco E, Ying H, Sherr DH, Hafer LJ, Rogers AE, Sonenshein GE, Xiao ZX. Increased expression of MDM2, cyclin D1, and p27Kip1 in carcinogen-induced rat mammary tumors. J Cell Biochem. 2005 Aug 1; 95(5):875-84. PMID: 15844214.

    Read at: PubMed
  • Published on 10/1/2004

    Wong V, Millen BE, Geller AC, Rogers AE, Maury JJ, Prout MN. What's in store for medical students? Awareness and utilization of expert nutrition guidelines among medical school preceptors. Prev Med. 2004 Oct; 39(4):753-9. PMID: 15351542.

    Read at: PubMed
  • Published on 1/1/2001

    Kavanagh KT, Hafer LJ, Kim DW, Mann KK, Sherr DH, Rogers AE, Sonenshein GE. Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem. 2001; 82(3):387-98. PMID: 11500915.

    Read at: PubMed
  • Published on 12/1/1999

    Rogers AE, Sullivan LM, Hafer LJ. Dietary fat, body weight, and cancer: contributions of studies in rodents to understanding these cancer risk factors in humans. Toxicol Sci. 1999 Dec; 52(2 Suppl):66-71. PMID: 10630593.

    Read at: PubMed
  • Published on 7/1/1998

    Rogers AE, Hafer LJ, Iskander YS, Yang S. Black tea and mammary gland carcinogenesis by 7,12-dimethylbenz[a]anthracene in rats fed control or high fat diets. Carcinogenesis. 1998 Jul; 19(7):1269-73. PMID: 9683188.

    Read at: PubMed
  • Published on 12/15/1997

    Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest. 1997 Dec 15; 100(12):2952-60. PMID: 9399940.

    Read at: PubMed
  • Published on 11/1/1997

    Rogers AE. Considerations in the design of studies of dietary influences on mammary carcinogenesis in rats and mice. Breast Cancer Res Treat. 1997 Nov-Dec; 46(2-3):247-54. PMID: 9478279.

    Read at: PubMed

View 11 more publications: View full profile at BUMC

View all profiles